Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

XPeng Q1 Adj. EPADS $(0.21) Beats $(0.27) Estimate, Sales $906.90M Beat $867.33M Estimate

Author: Benzinga Newsdesk | May 21, 2024 06:09am

XPeng (NYSE:XPEV) reported quarterly losses of $(0.21) per ADS which beat the analyst consensus estimate of $(0.27) by 22.22 percent. This is a 43.24 percent increase over losses of $(0.37) per ADS from the same period last year. The company reported quarterly sales of $906.90 million which beat the analyst consensus estimate of $867.33 million by 4.56 percent. This is a 54.42 percent increase over sales of $587.31 million the same period last year.

Posted In: XPEV